TreeWAS – Variant ID: rs9405490

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z43.2 Attention to ileostomy	0.000	0.901	0.099
H65-H75 Diseases of middle ear and mastoid	0.000	0.954	0.046
L85.8 Other specified epidermal thickening	0.045	0.955	0.000
H66 Suppurative and unspecified otitis media	0.000	0.956	0.044
H73 Other disorders of tympanic membrane	0.000	0.956	0.044
H74 Other disorders of middle ear and mastoid	0.000	0.956	0.044
H66.9 Otitis media, unspecified	0.000	0.957	0.043
L85.9 Epidermal thickening, unspecified	0.043	0.957	0.000
H73.8 Other specified disorders of tympanic membrane	0.000	0.958	0.042
L85 Other epidermal thickening	0.041	0.959	0.000
H72 Perforation of tympanic membrane	0.000	0.961	0.039
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.961	0.039
H69 Other disorders of Eustachian tube	0.000	0.961	0.039
H70 Mastoiditis and related conditions	0.000	0.962	0.038
H74.0 Tympanosclerosis	0.000	0.962	0.038
H72.0 Central perforation of tympanic membrane	0.000	0.963	0.037
H71 Cholesteatoma of middle ear	0.000	0.964	0.036
H69.9 Eustachian tube disorder, unspecified	0.000	0.965	0.034
H66.4 Suppurative otitis media, unspecified	0.000	0.966	0.034
Z43 Attention to artificial openings	0.000	0.966	0.034
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.966	0.034
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.966	0.033
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.967	0.033
H68 Eustachian salpingitis and obstruction	0.000	0.967	0.033
H67 Otitis media in diseases classified elsewhere	0.000	0.967	0.033
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.967	0.033
H70.9 Mastoiditis, unspecified	0.000	0.968	0.032
H66.0 Acute suppurative otitis media	0.000	0.968	0.032
H73.1 Chronic myringitis	0.000	0.968	0.031
H73.0 Acute myringitis	0.000	0.968	0.031
H74.1 Adhesive middle ear disease	0.000	0.969	0.031
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.969	0.031
H66.3 Other chronic suppurative otitis media	0.000	0.969	0.031
H74.4 Polyp of middle ear	0.000	0.969	0.031
Z43.1 Attention to gastrostomy	0.000	0.970	0.030
Z43.6 Attention to other artificial openings of urinary tract	0.000	0.970	0.030
L85.3 Xerosis cutis	0.030	0.970	0.000
L85.2 Keratosis punctata (palmaris et plantaris)	0.030	0.970	0.000
L85.1 Acquired keratosis [keratoderma] palmaris et plantaris	0.030	0.970	0.000
L85.0 Acquired ichthyosis	0.030	0.970	0.000
H69.0 Patulous Eustachian tube	0.000	0.972	0.028
H72.1 Attic perforation of tympanic membrane	0.000	0.972	0.028
H70.8 Other mastoiditis and related conditions	0.000	0.972	0.027
H70.2 Petrositis	0.000	0.972	0.027
H70.1 Chronic mastoiditis	0.000	0.972	0.027
H70.0 Acute mastoiditis	0.000	0.972	0.027
H65 Nonsuppurative otitis media	0.000	0.973	0.027
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.973	0.027
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.026	0.974	0.000
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.974	0.026
H69.8 Other specified disorders of Eustachian tube	0.000	0.974	0.026
H72.2 Other marginal perforations of tympanic membrane	0.000	0.975	0.025
Y40 Systemic antibiotics	0.025	0.975	0.000
Y40.0 Penicillins	0.025	0.975	0.000
Z43.9 Attention to unspecified artificial opening	0.000	0.975	0.025
Z43.7 Attention to artificial vagina	0.000	0.975	0.025
Y52.4 Angiotensin-converting-enzyme inhibitors	0.025	0.975	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.975	0.024
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.024	0.976	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.976	0.024
Z43.0 Attention to tracheostomy	0.000	0.976	0.024
Y45.0 Opioids and related analgesics	0.024	0.976	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.976	0.024
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.976	0.024
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.976	0.024
H68.1 Obstruction of Eustachian tube	0.000	0.976	0.024
H68.0 Eustachian salpingitis	0.000	0.976	0.024
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.976	0.024
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.976	0.024
Z43.4 Attention to other artificial openings of digestive tract	0.000	0.976	0.024
Y52 Agents primarily affecting the cardiovascular system	0.023	0.976	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.023	0.976	0.000
Y48 Anaesthetics and therapeutic gases	0.022	0.978	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.022	0.978	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.022	0.978	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.021	0.979	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.021	0.979	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.021	0.979	0.000
H65.0 Acute serous otitis media	0.000	0.979	0.021
Z43.5 Attention to cyctostomy	0.000	0.979	0.021
Z43.8 Attention to other artificial openings	0.000	0.980	0.020
Y45.5 4-Aminophenol derivatives	0.020	0.980	0.000
Y42.7 Androgens and anabolic congeners	0.020	0.980	0.000
Y40.8 Other systemic antibiotics	0.020	0.980	0.000
Y48.2 Other and unspecified general anaesthetics	0.020	0.980	0.000
H65.2 Chronic serous otitis media	0.000	0.980	0.020
H65.1 Other acute nonsuppurative otitis media	0.000	0.980	0.019
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.019	0.981	0.000
Y59 Other and unspecified vaccines and biological substances	0.019	0.981	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.981	0.019
Y45.2 Propionic acid derivatives	0.019	0.981	0.000
Y41.1 Antimycobacterial drugs	0.019	0.981	0.000
Y58 Bacterial vaccines	0.019	0.981	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.019	0.981	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.018	0.981	0.000
Y40.7 Antifungal antibiotics, systemically used	0.018	0.982	0.000
Y40.6 Rifamycins	0.018	0.982	0.000
Y40.5 Aminoglycosides	0.018	0.982	0.000
Y40.4 Tetracyclines	0.018	0.982	0.000
Y40.2 Chloramphenicol group	0.018	0.982	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.018	0.982	0.000
Y44 Agents primarily affecting blood constituents	0.018	0.982	0.000
Y40.9 Systemic antibiotic, unspecified	0.018	0.982	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.018	0.982	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.018	0.982	0.000
Y45.4 Antirheumatics	0.018	0.982	0.000
S01.5 Open wound of lip and oral cavity	0.018	0.982	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.017	0.983	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.017	0.983	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.017	0.983	0.000
Y52.7 Peripheral vasodilators	0.017	0.983	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.017	0.983	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.017	0.983	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.017	0.983	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.017	0.983	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.017	0.983	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.017	0.983	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.017	0.983	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.017	0.983	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.017	0.983	0.000
Y51.0 Anticholinesterase agents	0.017	0.983	0.000
Y45.8 Other analgesics and antipyretics	0.017	0.983	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.017	0.983	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.017	0.983	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.017	0.983	0.000
Y40.3 Macrolides	0.017	0.983	0.000
Y41.5 Antiviral drugs	0.017	0.983	0.000
Y42.5 Other oestrogens and progestogens	0.017	0.983	0.000
Y49.2 Other and unspecified antidepressants	0.016	0.984	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.984	0.016
Y48.5 Therapeutic gases	0.016	0.984	0.000
Y48.1 Parenteral anaesthetics	0.016	0.984	0.000
Y48.0 Inhaled anaesthetics	0.016	0.984	0.000
Y48.3 Local anaesthetics	0.016	0.984	0.000
Y49.5 Other antipsychotics and neuroleptics	0.016	0.984	0.000
Y42.9 Other and unspecified hormone antagonists	0.016	0.984	0.000
Y42.4 Oral contraceptives	0.016	0.984	0.000
Y42.2 Antithyroid drugs	0.016	0.984	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.984	0.016
Y42.1 Thyroid hormones and substitutes	0.016	0.984	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.015	0.984	0.000
Y41.4 Anthelminthics	0.015	0.984	0.000
Y41.3 Other antiprotozoal drugs	0.015	0.984	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.015	0.984	0.000
Y57 Other and unspecified drugs and medicaments	0.016	0.984	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.015	0.984	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.015	0.985	0.000
Y43 Primarily systemic agents	0.015	0.985	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.015	0.985	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.015	0.985	0.000
Y49.9 Psychotropic drug, unspecified	0.015	0.985	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.015	0.985	0.000
Y49.7 Psychostimulants with abuse potential	0.015	0.985	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.015	0.985	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.015	0.985	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.015	0.985	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.015	0.985	0.000
Y41.0 Sulphonamides	0.015	0.985	0.000
Q61.3 Polycystic kidney, unspecified	0.000	0.985	0.015
H65.3 Chronic mucoid otitis media	0.000	0.985	0.015
Y55.6 Antiasthmatics, not elsewhere classified	0.015	0.985	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.015	0.985	0.000
K65.0 Acute peritonitis	0.000	0.985	0.015
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.015	0.985	0.000
Y48.4 Anaesthetic, unspecified	0.014	0.985	0.000
Y59.3 Immunoglobulin	0.014	0.985	0.000
Q61 Cystic kidney disease	0.000	0.985	0.015
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.014	0.986	0.000
Y55.5 Anticommon cold drugs	0.014	0.986	0.000
Y55.4 Expectorants	0.014	0.986	0.000
Y55.3 Antitussives	0.014	0.986	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.014	0.986	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.014	0.986	0.000
Y55.0 Oxytocic drugs	0.014	0.986	0.000
Y52.1 Calcium-channel blockers	0.014	0.986	0.000
Y59.9 Vaccine or biological substance, unspecified	0.014	0.986	0.000
Y59.8 Other specified vaccines and biological substances	0.014	0.986	0.000
Y59.2 Protozoal vaccines	0.014	0.986	0.000
Y59.1 Rickettsial vaccines	0.014	0.986	0.000
Y59.0 Viral vaccines	0.014	0.986	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.014	0.986	0.000
Y50.9 Central nervous system stimulant, unspecified	0.014	0.986	0.000
Y50.8 Other central nervous system stimulants	0.014	0.986	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.014	0.986	0.000
Y50.1 Opioid receptor antagonists	0.014	0.986	0.000
Y50.0 Analeptics	0.014	0.986	0.000
Y58.9 Other and unspecified bacterial vaccines	0.014	0.986	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.014	0.986	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.014	0.986	0.000
Y58.5 Diphtheria vaccine	0.014	0.986	0.000
Y58.4 Tetanus vaccine	0.014	0.986	0.000
Y58.3 Plague vaccine	0.014	0.986	0.000
Y58.2 Cholera vaccine	0.014	0.986	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.014	0.986	0.000
Y58.0 BCG vaccine	0.014	0.986	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.013	0.987	0.000
Y44.7 Plasma substitutes	0.013	0.987	0.000
Y44.6 Natural blood and blood products	0.013	0.987	0.000
Y44.5 Thrombolytic drugs	0.013	0.987	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.013	0.987	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.013	0.987	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.013	0.987	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.013	0.987	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.013	0.987	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.013	0.987	0.000
Y47.4 Bromine compounds	0.013	0.987	0.000
Y47.3 Paraldehyde	0.013	0.987	0.000
Y47.2 Chloral derivatives	0.013	0.987	0.000
Y47.0 Barbiturates, not elsewhere classified	0.013	0.987	0.000
Y57.5 X-ray contrast media	0.013	0.987	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.013	0.987	0.000
Y54.3 Benzothiadiazine derivatives	0.013	0.987	0.000
Y56.9 Topical agent, unspecified	0.012	0.987	0.000
Y56.8 Other topical agents	0.012	0.987	0.000
Y56.7 Dental drugs, topically applied	0.012	0.987	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.012	0.987	0.000
Y56.5 Ophthalmological drugs and preparations	0.012	0.987	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.012	0.987	0.000
Y56.3 Emollients, demulcents and protectants	0.012	0.987	0.000
Y56.2 Local astringents and local detergents	0.012	0.987	0.000
Y56.1 Antipruritics	0.012	0.987	0.000
Y45.1 Salicylates	0.012	0.987	0.000
Y54.8 Agents affecting uric acid metabolism	0.012	0.987	0.000
Y54.9 Mineral salts, not elsewhere classified	0.012	0.988	0.000
Y54.7 Agents affecting calcification	0.012	0.988	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.012	0.988	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.012	0.988	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.012	0.988	0.000
Y54.0 Mineralocorticoids	0.012	0.988	0.000
Y46.8 Antispasticity drugs	0.012	0.988	0.000
Y46.7 Anti-Parkinsonism drugs	0.012	0.988	0.000
Y46.6 Other and unspecified antiepileptics	0.012	0.988	0.000
Y46.5 Valproic acid	0.012	0.988	0.000
Y46.3 Deoxybarbiturates	0.012	0.988	0.000
Y46.1 Oxazolidinediones	0.012	0.988	0.000
Y46.0 Succinimides	0.012	0.988	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.012	0.988	0.000
Y43.4 Immunosuppressive agents	0.012	0.988	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.012	0.988	0.000
Y53.7 Emetics	0.012	0.988	0.000
Y53.6 Antidiarrhoeal drugs	0.012	0.988	0.000
Y53.5 Digestants	0.012	0.988	0.000
Y53.3 Saline and osmotic laxatives	0.012	0.988	0.000
Y53.2 Stimulant laxatives	0.012	0.988	0.000
Y53.0 Histamine H2-receptor antagonists	0.012	0.988	0.000
Y43.0 Antiallergic and antiemetic drugs	0.012	0.988	0.000
Y47.1 Benzodiazepines	0.012	0.988	0.000
Y54.4 Loop [high-ceiling] diuretics	0.012	0.988	0.000
Y53.4 Other laxatives	0.012	0.988	0.000
Y46.2 Hydantoin derivatives	0.012	0.988	0.000
Y43.1 Antineoplastic antimetabolites	0.012	0.988	0.000
Y57.7 Vitamins, not elsewhere classified	0.011	0.989	0.000
Y57.4 Pharmaceutical excipients	0.011	0.989	0.000
Y57.3 Alcohol deterrents	0.011	0.989	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.011	0.989	0.000
Y57.1 Lipotropic drugs	0.011	0.989	0.000
Y57.0 Appetite depressants [anorectics]	0.011	0.989	0.000
Chapter VIII Diseases of the ear and mastoid process	0.000	0.989	0.011
Y43.9 Primarily systemic agent, unspecified	0.011	0.989	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.011	0.989	0.000
Y43.6 Enzymes, not elsewhere classified	0.011	0.989	0.000
Y43.5 Acidifying and alkalising agents	0.011	0.989	0.000
Y43.2 Antineoplastic natural products	0.011	0.989	0.000
Y46.4 Iminostilbenes	0.011	0.989	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.011	0.989	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.011	0.989	0.000
Z43.3 Attention to colostomy	0.000	0.989	0.011
Q61.9 Cystic kidney disease, unspecified	0.000	0.989	0.011
Q61.8 Other cystic kidney diseases	0.000	0.989	0.011
Q61.5 Medullary cystic kidney	0.000	0.989	0.011
Q61.4 Renal dysplasia	0.000	0.989	0.011
Q61.1 Polycystic kidney, infantile type	0.000	0.989	0.011
Y54.5 Other diuretics	0.010	0.989	0.000
Y57.6 Other diagnostic agents	0.010	0.990	0.000
H60-H62 Diseases of external ear	0.000	0.990	0.010
Y53.1 Other antacids and anti-gastric-secretion drugs	0.010	0.990	0.000
Y57.8 Other drugs and medicaments	0.010	0.990	0.000
M19.07 Primary arthrosis of other joints (Ankle and foot)	0.010	0.990	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.990	0.000
H60 Otitis externa	0.000	0.990	0.010
Q61.0 Congenital single renal cyst	0.000	0.991	0.009
H60.9 Otitis externa, unspecified	0.000	0.991	0.009
Y44.2 Anticoagulants	0.009	0.991	0.000
Q60-Q64 Congenital malformations of the urinary system	0.000	0.992	0.008
S01 Open wound of head	0.008	0.992	0.000
S01.4 Open wound of cheek and temporomandibular area	0.008	0.992	0.000
Y57.9 Drug or medicament, unspecified	0.008	0.992	0.000
H61 Other disorders of external ear	0.000	0.992	0.008
H60.3 Other infective otitis externa	0.000	0.992	0.008
H62 Disorders of external ear in diseases classified elsewhere	0.000	0.992	0.008
H61.2 Impacted cerumen	0.000	0.993	0.007
H60.5 Acute otitis externa, non-infective	0.000	0.993	0.007
Q60 Renal agenesis and other reduction defects of kidney	0.000	0.993	0.007
S01.7 Multiple open wounds of head	0.007	0.993	0.000
S01.2 Open wound of nose	0.007	0.993	0.000
H60.4 Cholesteatoma of external ear	0.000	0.993	0.007
H60.0 Abscess of external ear	0.000	0.993	0.007
H60.8 Other otitis externa	0.000	0.993	0.007
H61.9 Disorder of external ear, unspecified	0.000	0.993	0.007
H60.1 Cellulitis of external ear	0.000	0.993	0.007
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.993	0.007
Q60.0 Renal agenesis, unilateral	0.000	0.993	0.007
Q64 Other congenital malformations of urinary system	0.000	0.994	0.006
H60.2 Malignant otitis externa	0.000	0.994	0.006
Q63 Other congenital malformations of kidney	0.000	0.994	0.006
H61.0 Perichondritis of external ear	0.000	0.994	0.006
K56.5 Intestinal adhesions [bands] with obstruction	0.000	0.994	0.006
H62.8 Other disorders of external ear in diseases classified elsewhere	0.000	0.994	0.006
H62.4 Otitis externa in other diseases classified elsewhere	0.000	0.994	0.006
H62.3 Otitis externa in other infectious and parasitic diseases classified elsewhere	0.000	0.994	0.006
H62.2 Otitis externa in mycoses	0.000	0.994	0.006
H62.1 Otitis externa in viral diseases classified elsewhere	0.000	0.994	0.006
H62.0 Otitis externa in bacterial diseases classified elsewhere	0.000	0.994	0.006
N30.2 Other chronic cystitis	0.006	0.994	0.000
H61.1 Non-infective disorders of pinna	0.000	0.994	0.006
Q60.6 Potter's syndrome	0.000	0.994	0.005
Q60.5 Renal hypoplasia, unspecified	0.000	0.994	0.005
Q60.4 Renal hypoplasia, bilateral	0.000	0.994	0.005
Q60.3 Renal hypoplasia, unilateral	0.000	0.994	0.005
Q60.2 Renal agenesis, unspecified	0.000	0.994	0.005
Q60.1 Renal agenesis, bilateral	0.000	0.994	0.005
M19.0 Primary arthrosis of other joints	0.005	0.995	0.000
S05.8 Other injuries of eye and orbit	0.005	0.995	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.005	0.995	0.000
N85.2 Hypertrophy of uterus	0.000	0.995	0.005
Q62.5 Duplication of ureter	0.000	0.995	0.005
Q63.0 Accessory kidney	0.000	0.995	0.005
S01.0 Open wound of scalp	0.005	0.995	0.000
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.000	0.995	0.005
H61.3 Acquired stenosis of external ear canal	0.000	0.995	0.005
M19.02 Primary arthrosis of other joints (Upper arm)	0.005	0.995	0.000
S01.8 Open wound of other parts of head	0.005	0.995	0.000
K43.9 Ventral hernia without obstruction or gangrene	0.000	0.995	0.005
Q62.8 Other congenital malformations of ureter	0.000	0.995	0.005
Q62.7 Congenital vesico-uretero-renal reflux	0.000	0.995	0.005
Q62.6 Malposition of ureter	0.000	0.995	0.005
Q62.4 Agenesis of ureter	0.000	0.995	0.005
Q62.3 Other obstructive defects of renal pelvis and ureter	0.000	0.995	0.005
Q62.2 Congenital megaloureter	0.000	0.995	0.005
Q62.1 Atresia and stenosis of ureter	0.000	0.995	0.005
Q62.0 Congenital hydronephrosis	0.000	0.995	0.005
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.995	0.005
S01.9 Open wound of head, part unspecified	0.005	0.995	0.000
Chapter XX External causes of morbidity and mortality	0.005	0.995	0.000
Y04 Assault by bodily force	0.005	0.995	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.000	0.995	0.005
Q64.8 Other specified congenital malformations of urinary system	0.000	0.995	0.005
Q64.7 Other congenital malformations of bladder and urethra	0.000	0.995	0.005
Q64.6 Congenital diverticulum of bladder	0.000	0.995	0.005
Q64.5 Congenital absence of bladder and urethra	0.000	0.995	0.005
Q64.4 Malformation of urachus	0.000	0.995	0.005
Q64.2 Congenital posterior urethral valves	0.000	0.995	0.005
Q64.1 Exstrophy of urinary bladder	0.000	0.995	0.005
Q64.0 Epispadias	0.000	0.995	0.005
V20-V29 Motorcycle rider injured in transport accident	0.005	0.995	0.000
Z93.6 Other artificial openings of urinary tract status	0.000	0.995	0.005
K65 Peritonitis	0.000	0.995	0.005
V28 Motorcycle rider injured in noncollision transport accident	0.005	0.995	0.000
Y00-Y09 Assault	0.005	0.995	0.000
D41.4 Bladder	0.000	0.995	0.005
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.995	0.004
Q63.8 Other specified congenital malformations of kidney	0.000	0.995	0.004
Q63.3 Hyperplastic and giant kidney	0.000	0.995	0.004
M19.03 Primary arthrosis of other joints (Forearm)	0.004	0.995	0.000
X50-X57 Overexertion, travel and privation	0.004	0.995	0.000
H80-H83 Diseases of inner ear	0.000	0.995	0.005
V80-V89 Other land transport accidents	0.004	0.995	0.000
M19.04 Primary arthrosis of other joints (Hand)	0.004	0.995	0.000
A41.8 Other specified septicaemia	0.000	0.996	0.004
Y04.5 Trade and service area	0.004	0.996	0.000
Y04.2 School, other institution and public administrative area	0.004	0.996	0.000
H61.8 Other specified disorders of external ear	0.000	0.996	0.004
H92.0 Otalgia	0.000	0.996	0.004
V28.2 Unspecified motorcycle rider injured in nontraffic accident	0.004	0.996	0.000
Y04.8 Other specified place	0.004	0.996	0.000
V27 Motorcycle rider injured in collision with fixed or stationary object	0.004	0.996	0.000
N90.7 Vulvar cyst	0.004	0.996	0.000
X00-X09 Exposure to smoke, fire and flames	0.004	0.996	0.000
S05 Injury of eye and orbit	0.004	0.996	0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified	0.004	0.996	0.000
M19.08 Primary arthrosis of other joints (Other)	0.004	0.996	0.000
M19.06 Primary arthrosis of other joints-Lower leg	0.004	0.996	0.000
M19.05 Primary arthrosis of other joints (Pelvic region and thigh)	0.004	0.996	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.996	0.004
S01.1 Open wound of eyelid and periocular area	0.004	0.996	0.000
V28.5 Passenger injured in traffic accident	0.004	0.996	0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.004	0.996	0.000
W08.0 Home	0.004	0.996	0.000
X51 Travel and motion	0.004	0.996	0.000
M25.37 Other instability of joint (Ankle and foot)	0.004	0.996	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.996	0.004
R18 Ascites	0.000	0.996	0.004
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.004	0.996	0.000
X58-X59 Accidental exposure to other and unspecified factors	0.004	0.996	0.000
V01-V09 Pedestrian injured in transport accident	0.004	0.996	0.000
W75-W84 Other accidental threats to breathing	0.004	0.996	0.000
L29.0 Pruritus ani	0.004	0.996	0.000
A41 Other septicaemia	0.000	0.996	0.004
S00.5 Superficial injury of lip and oral cavity	0.004	0.996	0.000
Y10-Y34 Event of undetermined intent	0.004	0.996	0.000
H92 Otalgia and effusion of ear	0.000	0.996	0.004
S00.2 Other superficial injuries of eyelid and periocular area	0.004	0.996	0.000
V27.4 Driver injured in traffic accident	0.004	0.996	0.000
S00-S09 Injuries to the head	0.004	0.996	0.000
V98-V99 Other and unspecified transport accidents	0.004	0.996	0.000
V95-V97 Air and space transport accidents	0.004	0.996	0.000
V70-V79 Bus occupant injured in transport accident	0.004	0.996	0.000
Y04.9 Unspecified place	0.004	0.996	0.000
Y04.4 Street and highway	0.004	0.996	0.000
Y04.0 Home	0.004	0.996	0.000
Y04.7 Farm	0.004	0.996	0.000
Y04.6 Industrial and construction area	0.004	0.996	0.000
Y04.3 Sports and athletics area	0.004	0.996	0.000
Y04.1 Residential institution	0.004	0.996	0.000
H90-H95 Other disorders of ear	0.000	0.996	0.004
Y35-Y36 Legal intervention and operations of war	0.004	0.996	0.000
X85-X99 Assault	0.004	0.996	0.000
X30-X39 Exposure to forces of nature	0.004	0.996	0.000
W65-W74 Accidental drowning and submersion	0.004	0.996	0.000
V90-V94 Water transport accidents	0.004	0.996	0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.004	0.996	0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.004	0.996	0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic	0.004	0.996	0.000
V29 Motorcycle rider injured in other and unspecified transport accidents	0.004	0.996	0.000
V26 Motorcycle rider injured in collision with other nonmotor vehicle	0.004	0.996	0.000
V25 Motorcycle rider injured in collision with railway train or railway vehicle	0.004	0.996	0.000
V24 Motorcycle rider injured in collision with heavy transport vehicle or bus	0.004	0.996	0.000
V22 Motorcycle rider injured in collision with two- or three-wheeled motor vehicle	0.004	0.996	0.000
V21 Motorcycle rider injured in collision with pedal cycle	0.004	0.996	0.000
V20 Motorcycle rider injured in collision with pedestrian or animal	0.004	0.996	0.000
X10-X19 Contact with heat and hot substances	0.004	0.996	0.000
V28.9 Unspecified motorcycle rider injured in traffic accident	0.004	0.996	0.000
W08 Fall involving other furniture	0.004	0.996	0.000
X51.8 Other specified place	0.004	0.996	0.000
X50 Overexertion and strenuous or repetitive movements	0.004	0.996	0.000
Q63.2 Ectopic kidney	0.000	0.996	0.003
Y71 Cardiovascular devices associated with adverse incidents	0.004	0.996	0.000
H57.1 Ocular pain	0.004	0.996	0.000
M19.00 Primary arthrosis of other joints (Multiple sites)	0.004	0.996	0.000
V28.4 Driver injured in traffic accident	0.004	0.996	0.000
V28.0 Driver injured in nontraffic accident	0.004	0.996	0.000
V28.3 Person injured while boarding or alighting	0.004	0.996	0.000
V28.1 Passenger injured in nontraffic accident	0.004	0.996	0.000
V23 Motorcycle rider injured in collision with car, pick-up truck or van	0.004	0.996	0.000
Y09 Assault by unspecified means	0.003	0.996	0.000
Y08 Assault by other specified means	0.003	0.996	0.000
Y07 Other maltreatment syndromes	0.003	0.996	0.000
Y06 Neglect and abandonment	0.003	0.996	0.000
Y05 Sexual assault by bodily force	0.003	0.996	0.000
Y03 Assault by crashing of motor vehicle	0.003	0.996	0.000
Y02 Assault by pushing or placing victim before moving object	0.003	0.996	0.000
Y01 Assault by pushing from high place	0.003	0.996	0.000
A41.9 Septicaemia, unspecified	0.000	0.996	0.004
Y71.2 Prosthetic and other implants, materials and accessory devices	0.004	0.996	0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.004	0.996	0.000
V81 Occupant of railway train or railway vehicle injured in transport accident	0.003	0.996	0.000
X09 Exposure to unspecified smoke, fire and flames	0.003	0.996	0.000
W00-W19 Falls	0.004	0.996	0.000
Z93.2 Ileostomy status	0.000	0.996	0.004
Y60-Y69 Misadventures to patients during surgical and medical care	0.004	0.996	0.000
S00 Superficial injury of head	0.004	0.996	0.000
V59 Occupant of pick-up truck or van injured in other and unspecified transport accidents	0.003	0.996	0.000
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident	0.003	0.996	0.000
W17 Other fall from one level to another	0.004	0.996	0.000
H82 Vertiginous syndromes in diseases classified elsewhere	0.000	0.996	0.003
X57 Unspecified privation	0.003	0.996	0.000
X54 Lack of water	0.003	0.996	0.000
X53 Lack of food	0.003	0.996	0.000
X52 Prolonged stay in weightless environment	0.003	0.996	0.000
X40-X49 Accidental poisoning by and exposure to noxious substances	0.003	0.996	0.000
S06 Intracranial injury	0.004	0.996	0.000
V88 Nontraffic accident of specified type but victim's mode of transport unknown	0.003	0.996	0.000
V87 Traffic accident of specified type but victim's mode of transport unknown	0.003	0.996	0.000
V86 Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident	0.003	0.996	0.000
V85 Occupant of special construction vehicle injured in transport accident	0.003	0.996	0.000
V84 Occupant of special vehicle mainly used in agriculture injured in transport accident	0.003	0.996	0.000
V83 Occupant of special vehicle mainly used on industrial premises injured in transport accident	0.003	0.996	0.000
V82 Occupant of streetcar injured in transport accident	0.003	0.996	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.003	0.996	0.000
L29.2 Pruritus vulvae	0.003	0.997	0.000
S06.2 Diffuse brain injury	0.003	0.997	0.000
W29.9 Unspecified place	0.003	0.997	0.000
V89.9 Person injured in unspecified vehicle accident	0.003	0.997	0.000
W20-W49 Exposure to inanimate mechanical forces	0.003	0.997	0.000
V04 Pedestrian injured in collision with heavy transport vehicle or bus	0.003	0.997	0.000
D41.0 Kidney	0.000	0.997	0.003
X00 Exposure to uncontrolled fire in building or structure	0.003	0.997	0.000
M19.09 Primary arthrosis of other joints (Site unspecified)	0.003	0.997	0.000
V27.0 Driver injured in nontraffic accident	0.003	0.997	0.000
V27.9 Unspecified motorcycle rider injured in traffic accident	0.003	0.997	0.000
V27.5 Passenger injured in traffic accident	0.003	0.997	0.000
V27.3 Person injured while boarding or alighting	0.003	0.997	0.000
V27.2 Unspecified motorcycle rider injured in nontraffic accident	0.003	0.997	0.000
V27.1 Passenger injured in nontraffic accident	0.003	0.997	0.000
X59 Exposure to unspecified factor	0.003	0.997	0.000
W05 Fall involving wheelchair	0.003	0.997	0.000
W29 Contact with other powered hand tools and household machinery	0.003	0.997	0.000
W17.6 Industrial and construction area	0.003	0.997	0.000
X08 Exposure to other specified smoke, fire and flames	0.003	0.997	0.000
X06 Exposure to ignition or melting of other clothing and apparel	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations